Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LINCOLN NATIONAL CORPLNC · Entity 3631 | Director | December 31, 2024 | January 02, 2025 |
| Oscar Health, Inc.OSCR · Entity 3582 | President, Oscar Insurance | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LINCOLN NATIONAL CORP
Report date December 31, 2024 · Filed January 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitSEC Table II · derivative / convertible security | Direct | 29,222.17 |
Reported balance
After 2024-12-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-12-31 · Grant · Acquired 2,286.35 · Balance 29,222.17 F1: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3: Includes 356.82 shares acquired through dividend reinvestment since the reporting person's last report. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock.
F2: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time.
F3: Includes 356.82 shares acquired through dividend reinvestment since the reporting person's last report.
Oscar Health, Inc.
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 248,697 |
Reported balance
After 2026-09-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-03 · Sale · Disposed 10,360 · Balance 248,697 F1: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 8, 2026 20:22 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 10,360 | $31.45 | $325,822.00 |
DisclosureSEC source: 0001568651-26-000070 · wk-form4_1788898925.xml · nonDerivative · entry 1 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 248,697 F1 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 3,535 | $22.45 | $79,360.75 |
DisclosureSEC source: 0001888381-26-000004 · wk-form4_1780604170.xml · nonDerivative · entry 2 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 259,057 F1 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.03 to $22.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 8,940 | $21.74 | $194,355.60 |
DisclosureSEC source: 0001888381-26-000004 · wk-form4_1780604170.xml · nonDerivative · entry 1 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 262,592 F1 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $22.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 7,453 | $13.39 | $99,795.67 |
DisclosureSEC source: 0001568651-26-000027 · wk-form4_1772659417.xml · nonDerivative · entry 2 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,532 F3 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 106,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001568651-26-000027 · wk-form4_1772659417.xml · nonDerivative · entry 1 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,985 F1 · shares: The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service through each vesting date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:17 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 7,338 | $16.59 | $121,737.42 |
DisclosureSEC source: 0001888381-25-000006 · primarydocument.xml · nonDerivative · entry 1 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 172,527 F1 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.37 to $16.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Tax withholdingClass A Common Stock | 7,303 | $16.66 | $121,667.98 |
DisclosureSEC source: 0001888381-25-000004 · primarydocument.xml · nonDerivative · entry 1 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,865 F1 · shares: Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units("RSUs"). F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Tax withholdingClass A Common Stock | 7,196 | $13.80 | $99,304.80 |
DisclosureSEC source: 0001562180-25-004437 · primarydocument.xml · nonDerivative · entry 1 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,168 F1 · shares: Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units("RSUs"). F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:48 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 96,962 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-002212 · primarydocument.xml · nonDerivative · entry 1 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,364 F1 · shares: The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2025, subject to the reporting person's continuous service through each vesting date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:10 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantStock Options (Right to buy) · Derivative | 147,637 | $0.00 Strike: $15.27 | $0.00 |
DisclosureSEC source: 0001562180-25-001678 · primarydocument.xml · derivative · entry 2 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,637 Underlying: Class A Common Stock · 147,637 shares Expires 2035-02-24 F3 · derivative.exercise_date: The options will vest quarterly in 16 equal installments beginning on June 1, 2025, subject to the reporting persons continuous service through each vesting date. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:10 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 97,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001678 · primarydocument.xml · nonDerivative · entry 1 Liang Janet · CIK 0001888381 · President, Oscar Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,402 F1 · shares: The shares represent restricted stock units, which will vest quarterly in 16 equal installments beginning on June 1, 2025, subject to the reporting persons continuous service through each vesting date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 21:17 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 2,286.35 | $31.71 | $72,500.16 |
DisclosureSEC source: 0001214659-25-000052 · marketforms-67596.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,222.17 Underlying: Common Stock · 2,286.35 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 356.82 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:25 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 2,300.86 | $31.51 | $72,500.10 |
DisclosureSEC source: 0001214659-24-017043 · marketforms-66939.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,579.01 Underlying: Common Stock · 2,300.86 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 316.67 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| June 30, 2024 Filed Jul 1, 2024 21:23 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 2,331.19 | $31.10 | $72,500.01 |
DisclosureSEC source: 0001214659-24-011753 · marketforms-66271.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,961.48 Underlying: Common Stock · 2,331.19 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 345.90 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 20:21 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 2,270.59 | $31.93 | $72,499.94 |
DisclosureSEC source: 0001214659-24-005871 · marketforms-65295.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,284.39 Underlying: Common Stock · 2,270.59 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 317.01 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:21 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 2,549.13 | $26.97 | $68,750.04 |
DisclosureSEC source: 0001214659-24-000171 · marketforms-63795.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,696.79 Underlying: Common Stock · 2,549.13 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 331.95 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:19 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 2,784.53 | $24.69 | $68,750.05 |
DisclosureSEC source: 0001214659-23-013073 · marketforms-62637.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,815.71 Underlying: Common Stock · 2,784.53 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 204.18 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 18:14 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 2,668.87 | $25.76 | $68,750.09 |
DisclosureSEC source: 0001214659-23-009233 · marketforms-61777.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,827 Underlying: Common Stock · 2,668.87 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 206.56 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:22 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 3,059.64 | $22.47 | $68,750.11 |
DisclosureSEC source: 0001214659-23-004892 · marketforms-59889.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,951.57 Underlying: Common Stock · 3,059.64 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 88.81 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 21:23 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 2,237.96 | $30.72 | $68,750.13 |
DisclosureSEC source: 0001214659-23-000142 · marketforms-57742.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,803.12 Underlying: Common Stock · 2,237.96 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 37.76 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:20 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 1,565.7 | $43.91 | $68,749.89 |
DisclosureSEC source: 0001214659-22-011963 · marketforms-57162.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,527.41 Underlying: Common Stock · 1,565.7 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 25.95 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:22 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 1,469.96 | $46.77 | $68,750.03 |
DisclosureSEC source: 0001214659-22-008607 · marketforms-56526.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935.75 Underlying: Common Stock · 1,469.96 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 10.71 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:53 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 1,051.87 | $65.36 | $68,750.22 |
DisclosureSEC source: 0001214659-22-004781 · marketforms-55874.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,455.08 Underlying: Common Stock · 1,051.87 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F3 · balance_after: Includes 2.53 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:20 UTC | LINCOLN NATIONAL CORP LNC · Entity 3631 | GrantPhantom Stock Unit · Derivative | 400.68 | $68.26 | $27,350.42 |
DisclosureSEC source: 0001214659-22-000227 · marketforms-54740.xml · derivative · entry 1 Liang Janet · CIK 0001888381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400.68 Underlying: Common Stock · 400.68 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock unit is the equivalent of one share of LNC Common Stock. F2 · derivative.exercise_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. F2 · derivative.expiration_date: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the Deferred Compensation Plan for Non-Employee Directors (the "Plan"), which are payable solely in shares of the Company's common stock at resignation or retirement. The reporting person may transfer his/her Phantom Stock account into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.